Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by EbbFlow88on Oct 07, 2022 2:01pm
189 Views
Post# 35012800

RE:RE:New sub - 500K bb

RE:RE:New sub - 500K bb
gudisgood wrote: Also, having such large amounts of money in cash and financial assets is still dragging the operational performance. We have something like 44% of our market value in cash and financial assets! 



I think that's one of the main reasons this stock has lagged when the market was rising, but since the market has been getting killed the cash position has been outperforming and keeping our portfolios steady. My portolio has outperformed massively in 2022 mainly from my large position in GUD.

In the end though you are correct. We need to put that cash to work, and this is the turbulence to provide the opportunities. Either through companies like Endo going bankrupt, our own cheap stock or accretive bolt-ons.

I firmly believe this downturn/crash/depression will be what makes the future very bright for Knight.
<< Previous
Bullboard Posts
Next >>